Ke YC - Search Results

1

A new lateral flow plasmonic biosensor based on gold-viral biomineralized nanozyme for on-site intracellular glutathione detection to evaluate drug-resistance level.

Pang HH, Ke YC, Li NS, Chen YT, Huang CY, Wei KC, Yang HW. Pang HH, et al. Among authors: ke yc. Biosens Bioelectron. 2020 Oct 1;165:112325. doi: 10.1016/j.bios.2020.112325. Epub 2020 Jun 8. Biosens Bioelectron. 2020. PMID: 32729474

2

Thiolated Chitosan as an Intestinal Absorption Carrier with Hesperidin Encapsulation for Obesity Treatment.

Chen TC, Ho YY, Tang RC, Ke YC, Lin JN, Yang IH, Lin FH. Chen TC, et al. Among authors: ke yc. Nutrients. 2021 Dec 9;13(12):4405. doi: 10.3390/nu13124405. Nutrients. 2021. PMID: 34959957 Free PMC article.

3

Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD).

Ke YC, Chen TC, Tang RC, Lin JN, Lin FH. Ke YC, et al. APL Bioeng. 2022 Feb 8;6(1):016102. doi: 10.1063/5.0081695. eCollection 2022 Mar. APL Bioeng. 2022. PMID: 35178496 Free PMC article.

4

Differentiation Induction of Mesenchymal Stem Cells by a Au Delivery Platform.

Yang MY, Chiu CD, Ke YC, Yang YC, Chang KB, Chen CM, Lee HT, Tang CL, Liu BS, Hung HS. Yang MY, et al. Among authors: ke yc. Cells. 2023 Jul 19;12(14):1893. doi: 10.3390/cells12141893. Cells. 2023. PMID: 37508556 Free PMC article.

5

Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.

Liang F, Chen CY, Li YP, Ke YC, Ho EP, Jeng CF, Lin CH, Chen SK. Liang F, et al. Among authors: ke yc. J Parkinsons Dis. 2022;12(8):2423-2440. doi: 10.3233/JPD-223431. J Parkinsons Dis. 2022. PMID: 36155528

6

Tailoring key enzymes for renewable and high-level itaconic acid production using genetic Escherichia coli via whole-cell bioconversion.

Hsiang CC, Diankristanti PA, Tan SI, Ke YC, Chen YC, Effendi SSW, Ng IS. Hsiang CC, et al. Among authors: ke yc. Enzyme Microb Technol. 2022 Oct;160:110087. doi: 10.1016/j.enzmictec.2022.110087. Epub 2022 Jun 24. Enzyme Microb Technol. 2022. PMID: 35797847

7

Reply to: Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice through Activating TNF-α Pathway.

Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY, Wu CH, Liao PH, Hsu AY, Chu LA, Liu YD, Lin YH, Tai YC, Shun CT, Chiu HM, Wu MS. Lin CH, et al. Among authors: ke yc. Mov Disord. 2022 Mar;37(3):665-666. doi: 10.1002/mds.28947. Epub 2022 Jan 29. Mov Disord. 2022. PMID: 35092086 Free PMC article. No abstract available.

8

Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF-α Pathway.

Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY, Wu CH, Liao PH, Hsu AY, Chu LA, Liu YD, Lin YH, Tai YC, Shun CT, Chiu HM, Wu MS. Lin CH, et al. Among authors: ke yc. Mov Disord. 2022 Apr;37(4):745-757. doi: 10.1002/mds.28890. Epub 2021 Dec 17. Mov Disord. 2022. PMID: 34918781

9

Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease.

Lin YE, Lin CH, Ho EP, Ke YC, Petridi S, Elliott CJ, Sheen LY, Chien CT. Lin YE, et al. Among authors: ke yc. Elife. 2021 Nov 15;10:e73753. doi: 10.7554/eLife.73753. Elife. 2021. PMID: 34779396 Free PMC article.

10

Nanogold-Carried Graphene Oxide: Anti-Inflammation and Increased Differentiation Capacity of Mesenchymal Stem Cells.

Hung HS, Kung ML, Chen FC, Ke YC, Shen CC, Yang YC, Tang CM, Yeh CA, Hsieh HH, Hsu SH. Hung HS, et al. Among authors: ke yc. Nanomaterials (Basel). 2021 Aug 11;11(8):2046. doi: 10.3390/nano11082046. Nanomaterials (Basel). 2021. PMID: 34443877 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters